James Childs
Dermatology · College Station, TXNPI 1023150083
Payments from drug & device makers
Across 1,181 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$3K
- Mayne Pharma Commercial LLC$2K
- Amgen$1K
- Novartis$1K
- Incyte Corporation$1K
- AbbVie$973
- plus $10K from 30 others
What the payments were for
- Consulting fees$7004%
- Food & beverage$18,72595%
- Education$2211%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 98 | $2,591 |
| Mayne Pharma Commercial LLC | 259 | $2,123 |
| Amgen | 48 | $1,270 |
| Novartis | 145 | $1,194 |
| Incyte Corporation | 42 | $1,072 |
| AbbVie | 57 | $973 |
| Lilly USA, LLC | 44 | $973 |
| Galderma Laboratories, L.p. | 56 | $925 |
| Almirall LLC | 49 | $901 |
| Medimetriks Pharmaceuticals, Inc. | 17 | $860 |
| Sun Pharmaceutical Industries Inc. | 39 | $823 |
| Pfizer | 30 | $590 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 47 | $583 |
| Dermavant Sciences, Inc. | 24 | $573 |
| Arcutis Biotherapeutics, Inc. | 35 | $568 |
| Regeneron Healthcare Solutions, Inc. | 18 | $516 |
| LEO Pharma Inc. | 33 | $478 |
| E.r. Squibb & Sons, L.L.C. | 23 | $461 |
| Sanofi | 12 | $287 |
| VYNE Pharmaceuticals Inc. | 13 | $284 |
| Encore Dermatology Inc. | 33 | $282 |
| Organon | 14 | $273 |
| UCB, Inc. | 10 | $233 |
| Journey Medical Corporation | 6 | $136 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| EPI Health, LLC | 6 | $114 |
| Bristol Myers Squibb | 5 | $92 |
| Botanix SB Inc | 4 | $88 |
| Hill Dermaceuticals, Inc. | 2 | $60 |
| Strata Skin Sciences, Inc. | 3 | $37 |
| Elekta, Inc. | 1 | $37 |
| Glenmark Therapeutics Inc. | 2 | $35 |
| Mission Pharmacal Company | 2 | $32 |
| Tactile Systems Technology Inc | 1 | $25 |
| Dermira, Inc. | 1 | $19 |
| Nabriva Therapeutics, PLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$19,646 in reported general payments places this provider in the 80th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EucrisaCrisaborole | 12 | $8,901 |
| Clobetasol Propionate | 23 | $947 |
| Doxycycline Hyclate | 13 | $685 |
| Desonide | 11 | $411 |
| Imiquimod | 12 | $312 |
| Mupirocin | 16 | $104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEucrisa | $590 | $8,90112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,098 dermatology providers in Texas.
Other dermatology in College Station
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
- Janet DuboisAustin$3.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.